stockrowProPhase Labs, Inc. (PRPH) vs T2 Biosystems, Inc. (TTOO)
- ProPhase Labs, Inc. PRPH 0.01 0.00%
- T2 Biosystems, Inc. TTOO 0.00 NaN
ProPhase Labs, Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $1.2M — 5.5× the size. T2 Biosystems, Inc. grew revenue faster over the last twelve months: −30.2% against −43.5%. T2 Biosystems, Inc. has the higher net margin (−559.5% vs −717.4%) and the higher return on invested capital (0.00% vs −387.3%). Across the 16 metrics below, T2 Biosystems, Inc. leads on 9 and ProPhase Labs, Inc. on 7.
Valuation
Profitability
| Metric | PRPH | TTOO | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 16.38% | (76.76%) | 48.32% |
| Operating margin | (498.73%) | (542.59%) | (5.68%) |
| Net margin | (717.43%) | (559.52%) | (4.10%) |
| Free cash flow margin | (175.22%) | (476.64%) | 0.00% |
| Return on equity | (543.95%) | 277.61% | 0.00% |
| Return on assets | (45.53%) | (140.00%) | (6.05%) |
| Return on invested capital | (387.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack